Post Profile

23andMe confirms $250 million round led by Sequoia

Genetics testing company 23andMe has formally announced that Sequoia Capital is leading an investment round in the company. This confirms the news we broke last week.  The press release says that the final amount was $250 million and that Sequoia’s Roelof Botha will be taking a board seat. Others participating in the round include new investors Euclidean Capital, Altimeter Capital and…
read more


Related Posts

23andMe is raising about $200 million, led by Sequoia

Technology / Technology Industry News : TechCrunch: Funding and Exits

23andMe is raising close to $200 million in a funding round led by Sequoia, multiple sources tell us. We’re also hearing that Fidelity is looking to participate. We’ve heard for a while the personal genetics company was looking for ...

23andMe Plans Further Expansion, Secures $250 In New Funding

Business & Finance : Fast Company

DNA-testing company 23andMe just announced it has secured $250 million in funding. According to a press release, Sequoia Capital is leading the startup’s latest round, along with new investors including Euclidean Capital, Altimeter ...

GitHub confirms that it has raised $250M, led by Sequoia Capital

Technology : Venture Beat

Source code repository software company GitHub has raised a $250 million series B funding round, with top-tier venture capital firm Sequoia Capital leading the round. Andreessen Horowitz, Thrive Capital, and Institutional Venture Pa...

23andMe gets $200 million in funding to bring its genetic testing to the masses

Technology / Technology Industry News : Silicon Alley Insider

23andMe, the DNA testing company that turns saliva into in-depth genetic analysis, is raising $200 million in funding led by Sequoia Capital, sources close to the situation confirmed to Business Insider. This puts the company at a p...

23andMe is getting serious about drug development — and it could signal a fresh approach to finding new medicines

Technology / Technology Industry News : Silicon Alley Insider

23andMe, a company known for its consumer genetics test, is also looking to develop new drugs. The company raised $250 million on Tuesday, and the funding will in part go toward drug development. While drug development and consumer ...


Technology Industry News
Copyright © 2016 Regator, LLC